BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//talks.cam.ac.uk//v3//EN
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:19700329T010000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=-1SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:19701025T020000
RRULE:FREQ=YEARLY;BYMONTH=10;BYDAY=-1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
CATEGORIES:IET
SUMMARY:ONLINE WEBINAR - The Breath Biopsy® Platform  - Bi
 lly Boyle\, Owlstone.
DTSTART;TZID=Europe/London:20210311T183000
DTEND;TZID=Europe/London:20210311T193000
UID:TALK153370AThttp://talks.cam.ac.uk
URL:http://talks.cam.ac.uk/talk/index/153370
DESCRIPTION:Cancer killed 8.8 million people in 2015 alone. It
  is a stark reality that 1 in 2 of us will get can
 cer. From our parents to our partners\, our childr
 en\, our grandchildren - 1 in 2 will get cancer. W
 e must find better ways to treat cancer\, but more
  importantly better ways to detect cancer earlier\
 , when chances of a cure are dramatically higher.\
 nEvery time you breathe out there are thousands of
  chemicals on your breath\, some of these are mark
 ers of cancer.\nThis talk will provide an overview
  of the research currently being undertaken in Cam
 bridge by Owlstone Medical Ltd using our Breath Bi
 opsy® platform to “sniff” out these chemical marke
 rs to detect cancer earlier.\nOur greatest opportu
 nity lies not in developing new drugs but increasi
 ng rates of early diagnosis through improved cance
 r screening. \n\nSpeaker Profile\nBilly Boyle is a
 n engineering graduate from the University of Camb
 ridge. He is one of the original co-founders of Ow
 lstone Inc\, spun out of Cambridge in 2004\, which
  has raised $28M in investment and won >$25M in de
 fence contracts. He initially worked with silicon 
 foundries in the design and fabrication of the cor
 e microchip technology and is co-inventor on 19 pa
 tents. He then assumed a commercial role with P&L 
 responsibility for the Scientific Instruments and 
 Industrial business units\; responsible for sales 
 of FAIMS products and contracts with >150 clients 
 globally\, including Agilent\, Thermo\, Roche Diag
 nostics\, Samsung\, GSK\, 4D Pharma\, Mayo Clinic 
 and the NHS.\nBilly started to focus on the medica
 l applications of FAIMS technology after his wife\
 , Kate\, was diagnosed and later died of colon can
 cer as a result of a late diagnosis. He worked clo
 sely with clinical partners who integrated FAIMS t
 echnology across a broad spectrum of clinical tria
 ls in cancer\, inflammatory disease & infectious d
 isease.\nAfter positive clinical trial results he 
 headed up the newly formed Medical business unit\,
  which won a £1M NHS contract for LuCID to use FAI
 MS technology in the early detection of lung cance
 r. With ongoing clinical and commercial success\, 
 Billy led the process to spin out Owlstone Medical
  Ltd and became the founding CEO upon the close of
  a $7M investment in March 2016. The mission of Ow
 lstone Medical is to save 100\,000 lives and $1.5B
  in healthcare costs.\nBilly was made a Fellow of 
 the Royal Academy of Engineering in 2020. \n\nTo m
 ake a booking please go to https://localevents.the
 iet.org/bb846e
LOCATION: Webinar  (via Zoom online)- link to follow
CONTACT:David Blake
END:VEVENT
END:VCALENDAR